Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus

References

• Ogston A. Micrococcus poisoning. J Anat Physiol. 1882;16:526–567.
   Google Scholar
• Kourtis AP, Hatfield K, Baggs J, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections − United States. Morb Mortal Wkly Rep. 2019;68:214–219. doi:10.15585/mmwr.mm6809e1
   PubMed Web of Science ®Google Scholar
• Jones M, Jernigan JA, Evans ME, et al. Vital signs: trends in Staphylococcus aureus infections in veterans affairs medical centers — United States, 2005–2017. Morb Mortal Wkly Rep. 2019;68:220–224. doi:10.15585/mmwr.mm6809e2
   Web of Science ®Google Scholar
• Harkins CP, Pichon B, Doumith M, et al. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 2017;18:130. doi:10.1186/s13059-017-1252-928724393
   PubMed Web of Science ®Google Scholar
• Che Hamzah AM, Yeo CC, Puah SM, et al. Infections in Malaysia: a review of antimicrobial resistance and characteristics of the clinical isolates, 1990–2017. Antibiotics. 2019;8:128.
   Web of Science ®Google Scholar
• Chen Z, Lai XX, Zhang L, et al. [Distribution and drug resistance of pathogens in infected organ donors from donation after the citizen death]. Zhonghua Yi Xue Za Zhi. 2018;98:181–185. doi:10.3760/cma.j.issn.0376-2491.2018.03.00529374911
   PubMedGoogle Scholar
• Li L, Dai JX, Xu L, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine. 2018;97.
   Web of Science ®Google Scholar
• Lewis PO, Heil EL, Covert KL, et al. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Pharm Therap. 2018;43:614–625. doi:10.1111/jcpt.1274330003555
   PubMed Web of Science ®Google Scholar
• Hendlin D, Stapley EO, Jackson M, et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science. 1969;166:122–123.5809587
   PubMed Web of Science ®Google Scholar
• Falagas ME, Vouloumanou EK, Samonis G, et al. Fosfomycin. Clin Microbiol Rev. 2016;29:321–347. doi:10.1128/CMR.00068-1526960938
   PubMed Web of Science ®Google Scholar
• Richter DC, Brenner T, Brinkmann A, et al. [Infections due to multidrug-resistant pathogens: pathogens, resistance mechanisms and established treatment options]. Anaesthesist. 2019;68:711–730. German.31555833
   PubMed Web of Science ®Google Scholar
• Wu D, Chen Y, Sun L, et al. Prevalence of fosfomycin resistance in methicillin-resistant Staphylococcus aureus isolated from patients in a university hospital in China from 2013 to 2015. Jpn J Infect Dis. 2018;71:312–314. doi:10.7883/yoken.JJID.2018.01329709971
   PubMed Web of Science ®Google Scholar
• Ayerbe-Algaba R, Gil-Marqués ML, Jiménez-Mejías ME, et al. Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:348. doi:10.3389/fcimb.2018.0034830338245
   PubMed Web of Science ®Google Scholar
• Chai D, Liu X, Wang R, et al. Efficacy of linezolid and fosfomycin in catheter-related biofilm infection caused by methicillin-resistant Staphylococcus aureus. Biomed Res Int. 2016;2016.
   Web of Science ®Google Scholar
• Yuenyongviwat V, Ingviya N, Pathaburee P, et al. Inhibitory effects of vancomycin and fosfomycin on methicillin-resistant Staphylococcus aureus from antibiotic-impregnated articulating cement spacers. Bone Joint Res. 2017;6:132–136. doi:10.1302/2046-3758.63.200063928258116
   PubMed Web of Science ®Google Scholar
• Kouda M. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems]. Jpn J Antibiot. 1993;46:142–153. Japanese.8331774
   PubMedGoogle Scholar
• Teng Z, Li M, Shi D, et al. Synergistic interactions of cryptotanshinone and aminoglycoside antibiotics against Staphylococcus aureus in vitro. J Glob Antimicrob Resist. 2018;13:264–265. doi:10.1016/j.jgar.2018.05.01329807203
   PubMed Web of Science ®Google Scholar
• Feng H, Xiang H, Zhang J, et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone. J Biomed Biotechnol. 2009;2009:617509. doi:10.1155/2009/61750919707532
   PubMedGoogle Scholar
• Fu Z, Ma Y, Chen C, et al. Prevalence of fosfomycin resistance and mutations in murA, glpT, and uhpT in methicillin-resistant Staphylococcus aureus strains isolated from blood and cerebrospinal fluid samples. Front Microbiol. 2015;6:1544.26793179
   PubMed Web of Science ®Google Scholar
• Shin JH, Kim MN, Jang SJ, et al. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol. 2012;50:1852–1855. doi:10.1128/JCM.06440-1122442324
   PubMed Web of Science ®Google Scholar
• Fratini F, Mancini S, Turchi B, et al. A novel interpretation of the fractional inhibitory concentration index: the case origanum vulgare L. and Leptospermum scoparium J. R. et G. Forst essential oils against Staphylococcus aureus strains. Microbiol Res. 2017;195:11–17. doi:10.1016/j.micres.2016.11.00528024521
   PubMed Web of Science ®Google Scholar
• Noel A, Attwood M, Bowker K, et al. The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection. Int J Antimicrob Agents. 2020;56(1):105985. doi:10.1016/j.ijantimicag.2020.10598532330585
   PubMed Web of Science ®Google Scholar
• Shi J, Mao NF, Wang L, et al. Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo. PLoS One. 2014;9:e113133.25551618
   PubMed Web of Science ®Google Scholar
• Fu Z, Liu Y, Chen C, et al. Characterization of fosfomycin resistance gene, fosB, in methicillin-resistant Staphylococcus aureus isolates. PLoS One. 2016;11:e0154829.27144405
   PubMed Web of Science ®Google Scholar
• Ito R, Tomich AD, McElheny CL, et al. Inhibition of fosfomycin resistance protein FosA by phosphonoformate (Foscarnet) in multidrug-resistant gram-negative pathogens. Antimicrob Agents Chemother. 2017;61.
   Web of Science ®Google Scholar
• Etienne J, Gerbaud G, Fleurette J, et al. Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB. FEMS Microbiol Lett. 1991;68:119–122. doi:10.1111/j.1574-6968.1991.tb04580.x1769548
   PubMed Web of Science ®Google Scholar
• DiCicco M, Weese S, Neethirajan S, et al. Fosfomycin susceptibility of canine methicillin-resistant Staphylococcus pseudintermedius isolates. Res Vet Sci. 2014;96:251–253. doi:10.1016/j.rvsc.2014.02.00424569298
   PubMed Web of Science ®Google Scholar
• Takahata S, Ida T, Hiraishi T, et al. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents. 2010;35:333–337. doi:10.1016/j.ijantimicag.2009.11.01120071153
   PubMed Web of Science ®Google Scholar
• Kahan FM, Kahan JS, Cassidy PJ, et al. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci. 1974;235:364–386.4605290
   PubMed Web of Science ®Google Scholar
• Roberts AA, Sharma SV, Strankman AW, et al. Mechanistic studies of FosB: a divalent-metal-dependent bacillithiol-S-transferase that mediates fosfomycin resistance in Staphylococcus aureus. Biochem J. 2013;451:69–79. doi:10.1042/BJ2012154123256780
   PubMed Web of Science ®Google Scholar
• Fillgrove KL, Pakhomova S, Newcomer ME, et al. Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms. J Am Chem Soc. 2003;125:15730–15731. doi:10.1021/ja039307z14677948
   PubMed Web of Science ®Google Scholar
• Chen H, Li L, Liu Y, et al. In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of. Infect Drug Resist. 2018;11:2107–2115. doi:10.2147/IDR.S17597830464553
   PubMed Web of Science ®Google Scholar
• Gobernado M. [Fosfomycin]. Revista espanola de quimioterapia. 2003;16:15–40.12750755
   PubMedGoogle Scholar
• Cha JD, Lee JH, Choi KM, et al. Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus. Evid Based Complement Alternat Med. 2014;2014:1–16. doi:10.1155/2014/450572
   Web of Science ®Google Scholar
• Chen W, Liu L, Luo Y, et al. Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells. Cancer Prev Res. 2012;5:778–787. doi:10.1158/1940-6207.CAPR-11-0551
   PubMed Web of Science ®Google Scholar